At Marbury Law Group, we believe that innovation isn't just about adopting new technology - it's about mastering it ethically, responsibly, and strategically to better serve our clients. That is why we were proud to host the Marbury Law Group AI Summit 2025 on October 28-29, 2025. This intensive, two-day event brought together all of [...]
Marbury Partner Michelle E. O'Brien and Senior Partner Tom Irving will present at the AIPLA Patent Prosecution Boot Camp in San Jose, CA on February 7-9, 2024. Michelle will lead a 4-hour claims drafting workshop focusing on Chemical, Biotech, and Pharmaceutical technologies, and Tom will present on Ethics and the Duty of Candor. For more [...]
Michelle O'Brien and Tom Irving will present "Low-Hanging Fruit: The FTC’s Recent Actions Scrutinizing Patent Listings in the Orange Book" to AIPLA's Food and Drug Law Committee on January 18, 2024, at 2 pm ET. The FTC has had an interest in what it believes to be improperly listed patents and has a history of [...]
By Scott B. Amankwatia "Decoding Motivation to Combine Principles in Key Rulings" as published in the 2023 APELLATE YEAR IN REVIEW from the PTAB Bar Association (Download the PDF here) In 2023, the Federal Circuit issued several opinions addressing motivation to combine in the context of inter partes review. As we will see in Axonics [...]
Tom Irving, Senior Partner, will co-present a Strafford Webinar "Challenging Pending Patent Applications: When, Where, and What Type" on Monday, November 13, 2023, at 1:00 p.m. Eastern time. The panel will examine options for challenging pending patent applications at the USPTO, including pre-issuance submissions of relevant prior art, protests, and derivation proceedings. They will also [...]
Senior Partner Tom Irving and Partner Michelle O'Brien will participate in a Strafford Webinar on Thursday, November 2, 2023, from 1:00-2:30 p.m. discussing patent applicants' duty of disclosure to the USPTO during prosecution. The panel will address various considerations for ensuring the duty is satisfied, as well as offer tips on best practices for information [...]
On October 16, 2023, Marbury Senior Partner Tom Irving and Partner Michelle O'Brien will be presenting a webinar on Obviousness-Type Double Patenting and discussing the Federal Circuit's In re Cellect decision. In Cellect, the CAFC found that ODP was to be evaluated after PTA is added on to patent term, potentially impacting whether a patent [...]
Marbury Senior Partner Tom Irving will be speaking at ACI’s Hatch-Waxman and BPCIA Proficiency Series, a virtual three-week program designed to provide new lawyers and executives for the life sciences industry with a solid foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA litigation and regulation. The program runs from [...]
On October 11, 2023, Tom Irving will join a Strafford webinar titled "Patent Drafting for Multiple Jurisdictions." The panel will discuss important considerations for patent counsel when drafting a patent application that will be prosecuted in different patent offices around the world, such as grace periods, data considerations, choice of language, and terminology. The panel [...]
On September 19-20, Marbury Senior Partner Tom Irving and Partner Michelle O'Brien will join American Intellectual Property Law Association (AIPLA)'s Chemical Practice and Biotechnology Committees to present a two-day AIPLA CLE Web Series: "Hot Topics in Chemical and Pharmaceutical Patent Practice." Tom will moderate an expert panel on day 1 where the duty of candor, [...]
